Current status:
Cancelled Post Market
Current status date:
2007-07-31
Product name:
BRETYLIUM TOSYLATE 0.4% AND DEXTROSE 5% INJ
DIN:
00655724
Electronic product monograph is not available
Route(s) of administration:
Intravenous
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
24:04.04.20
Anatomical Therapeutic Chemical (ATC):
See footnote 4
C01BD02 BRETYLIUM TOSILATE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
BRETYLIUM TOSYLATE
|
4 MG / ML
|
DEXTROSE
|
50 MG / ML
|